These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26754479)

  • 1. Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion Syndrome.
    Crutcher E; Ali M; Harrison J; Sovago J; Gomez-Mancilla B; Schaaf CP
    J Autism Dev Disord; 2016 Apr; 46(4):1455-63. PubMed ID: 26754479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes.
    Forsingdal A; Fejgin K; Nielsen V; Werge T; Nielsen J
    Transl Psychiatry; 2016 Jul; 6(7):e860. PubMed ID: 27459725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
    Kogan JH; Gross AK; Featherstone RE; Shin R; Chen Q; Heusner CL; Adachi M; Lin A; Walton NM; Miyoshi S; Miyake S; Tajinda K; Ito H; Siegel SJ; Matsumoto M
    J Neurosci; 2015 Dec; 35(49):16282-94. PubMed ID: 26658876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders.
    Miller DT; Shen Y; Weiss LA; Korn J; Anselm I; Bridgemohan C; Cox GF; Dickinson H; Gentile J; Harris DJ; Hegde V; Hundley R; Khwaja O; Kothare S; Luedke C; Nasir R; Poduri A; Prasad K; Raffalli P; Reinhard A; Smith SE; Sobeih MM; Soul JS; Stoler J; Takeoka M; Tan WH; Thakuria J; Wolff R; Yusupov R; Gusella JF; Daly MJ; Wu BL
    J Med Genet; 2009 Apr; 46(4):242-8. PubMed ID: 18805830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.
    Ben-Shachar S; Lanpher B; German JR; Qasaymeh M; Potocki L; Nagamani SC; Franco LM; Malphrus A; Bottenfield GW; Spence JE; Amato S; Rousseau JA; Moghaddam B; Skinner C; Skinner SA; Bernes S; Armstrong N; Shinawi M; Stankiewicz P; Patel A; Cheung SW; Lupski JR; Beaudet AL; Sahoo T
    J Med Genet; 2009 Jun; 46(6):382-8. PubMed ID: 19289393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
    Uddin M; Unda BK; Kwan V; Holzapfel NT; White SH; Chalil L; Woodbury-Smith M; Ho KS; Harward E; Murtaza N; Dave B; Pellecchia G; D'Abate L; Nalpathamkalam T; Lamoureux S; Wei J; Speevak M; Stavropoulos J; Hope KJ; Doble BW; Nielsen J; Wassman ER; Scherer SW; Singh KK
    Am J Hum Genet; 2018 Feb; 102(2):278-295. PubMed ID: 29395074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Effects of the 15q13.3 Microdeletion on the Transcriptome and Epigenome in Human-Induced Neurons.
    Zhang S; Zhang X; Purmann C; Ma S; Shrestha A; Davis KN; Ho M; Huang Y; Pattni R; Wong WH; Bernstein JA; Hallmayer J; Urban AE
    Biol Psychiatry; 2021 Mar; 89(5):497-509. PubMed ID: 32919612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature.
    Lowther C; Costain G; Stavropoulos DJ; Melvin R; Silversides CK; Andrade DM; So J; Faghfoury H; Lionel AC; Marshall CR; Scherer SW; Bassett AS
    Genet Med; 2015 Feb; 17(2):149-57. PubMed ID: 25077648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex behavioral phenotype of 15q13.3 microdeletion syndrome.
    Ziats MN; Goin-Kochel RP; Berry LN; Ali M; Ge J; Guffey D; Rosenfeld JA; Bader P; Gambello MJ; Wolf V; Penney LS; Miller R; Lebel RR; Kane J; Bachman K; Troxell R; Clark G; Minard CG; Stankiewicz P; Beaudet A; Schaaf CP
    Genet Med; 2016 Nov; 18(11):1111-1118. PubMed ID: 26963284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice.
    Stoppel LJ; Kazdoba TM; Schaffler MD; Preza AR; Heynen A; Crawley JN; Bear MF
    Neuropsychopharmacology; 2018 Feb; 43(3):513-524. PubMed ID: 28984295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Following the Trail From Genotype to Phenotypes.
    Lord C; Veenstra-VanderWeele J
    JAMA Psychiatry; 2016 Jan; 73(1):7-8. PubMed ID: 26630619
    [No Abstract]   [Full Text] [Related]  

  • 13. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients.
    Città S; Buono S; Greco D; Barone C; Alfei E; Bulgheroni S; Usilla A; Pantaleoni C; Romano C
    Am J Med Genet A; 2013 Dec; 161A(12):3018-22. PubMed ID: 24214349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
    Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterative phenotyping of 15q11.2, 15q13.3 and 16p13.11 microdeletion carriers in pediatric epilepsies.
    Jähn JA; von Spiczak S; Muhle H; Obermeier T; Franke A; Mefford HC; Stephani U; Helbig I
    Epilepsy Res; 2014 Jan; 108(1):109-16. PubMed ID: 24246141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome.
    Yin J; Chen W; Chao ES; Soriano S; Wang L; Wang W; Cummock SE; Tao H; Pang K; Liu Z; Pereira FA; Samaco RC; Zoghbi HY; Xue M; Schaaf CP
    Am J Hum Genet; 2018 Feb; 102(2):296-308. PubMed ID: 29395075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.
    Murphy MM; Lindsey Burrell T; Cubells JF; España RA; Gambello MJ; Goines KCB; Klaiman C; Li L; Novacek DM; Papetti A; Sanchez Russo RL; Saulnier CA; Shultz S; Walker E; Mulle JG
    BMC Psychiatry; 2018 Jun; 18(1):183. PubMed ID: 29884173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.
    Giovanoli S; Werge TM; Mortensen PB; Didriksen M; Meyer U
    Neuropsychopharmacology; 2019 Mar; 44(4):703-710. PubMed ID: 30188511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing cognitive control abilities in children with 16p11.2 deletion using adaptive 'video game' technology: a pilot study.
    Anguera JA; Brandes-Aitken AN; Rolle CE; Skinner SN; Desai SS; Bower JD; Martucci WE; Chung WK; Sherr EH; Marco EJ
    Transl Psychiatry; 2016 Sep; 6(9):e893. PubMed ID: 27648915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations.
    Fejgin K; Nielsen J; Birknow MR; Bastlund JF; Nielsen V; Lauridsen JB; Stefansson H; Steinberg S; Sorensen HB; Mortensen TE; Larsen PH; Klewe IV; Rasmussen SV; Stefansson K; Werge TM; Kallunki P; Christensen KV; Didriksen M
    Biol Psychiatry; 2014 Jul; 76(2):128-37. PubMed ID: 24090792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.